Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07531264 · ClinicalTrials.gov registry record · Early Phase 1
Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction in Chronic Stroke
A Early Phase 1 study, sponsored by University of Houston.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 48
- Enrollment target
NCT07531264: Clinical Trial Early Phase 1 study, sponsored by University of Houston.
NCT07531264 is a Early Phase 1 study that has not yet begun recruiting, run by University of Houston. The registered enrollment target is 48 participants, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07531264, a Early Phase 1 study, has not yet begun recruiting, sponsored by University of Houston.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 48 participants
- Enrollment target
Study Summary
The objective of this study is to develop Neuro-Intermuscular Coordination Enhancement (NICE) rehabilitation, a novel neuromuscular control signal-guided strategy that visually guides stroke patients to individually activate motor modules through human-machine interaction. Ultimately, the development will lead to better clinical motor recovery, better quality of life, and lowered healthcare costs associated with the impairment.
Primary Outcome
Motor impairment after stroke will be measured by upper extremity FMA (UE-FMA). The maximum UE-FMA motor score is 66 (i.e., 0: complete motor impairment; 66: normal motor performance). Each item is scored on a 3-point scale (0 = cannot perform, 1 = performs partially, 2 = performs fully). The FMA score reflects the level of upper extremity motor impairment.
Interventions
- OTHER Neuromuscular coordination enhancement (NICE) intervention
- OTHER EMG Amplitude Biofeedback Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2027-08 |
| Est. Completion | 2032-08 |
| Phase | Early Phase 1 |
What is known before NCT07531264 opens enrollment
NCT07531264 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, roughly in line with the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Neuromuscular coordination enhancement (NICE) intervention is the first listed.
NCT07531264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07531264 about?
NCT07531264 is a clinical study titled "Neuro-Intermuscular Coordination Enhancement (NICE) Rehabilitation Through Human-Machine Interaction in Chronic Stroke". The objective of this study is to develop Neuro-Intermuscular Coordination Enhancement (NICE) rehabilitation, a novel neuromuscular control signal-guided strategy that visually guides stroke patients to individually activate motor modules through human-machine interaction. Ultimately, the developmen...
What is the current status of trial NCT07531264?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 48 participants. The study started on 2027-08. Estimated completion is 2032-08.
What interventions are being tested in trial NCT07531264?
The interventions under investigation include: Neuromuscular coordination enhancement (NICE) intervention (OTHER), EMG Amplitude Biofeedback Exercise (OTHER).
Who is sponsoring clinical trial NCT07531264?
This trial is sponsored by University of Houston, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07531264's enrollment target sits among peer trials
48 541st of 2000 higher than 1,438 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia